Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) are medications that are used to treat HIV infection and AIDS. These inhibitors work by binding to the HIV-1 reverse transcriptase enzymes, which are responsible for converting the virus’s RNA into new DNA. By binding to these enzymes, NNRTIs prevent the replication of the virus, thereby reducing the viral load in the body. Additionally, they can also lower the chances of developing resistance to other HIV medications and alleviate the symptoms of the virus.
Although NNRTIs are effective in treating HIV, they may cause some side effects. These can include bone-marrow suppression, vomiting, muscle and abdominal pain, and rash. It is important to consult with a healthcare professional to determine the most appropriate treatment plan and to monitor for any adverse reactions.
Fusion Inhibitors: Preventing HIV Infection
Fusion inhibitors, commonly referred to as FIs, play a crucial role in impeding HIV from infiltrating healthy cells. By obstructing the spike-shaped HIV envelope from merging with a white blood cell’s membrane, FIs effectively prevent the virus from entering the cell and causing infection. Not only do fusion inhibitors delay the progression of HIV, but they also empower compromised immune systems to effectively combat other infections. However, it is important to note that there can be potential side effects associated with the use of fusion inhibitors, such as swelling of the lips, mouth, or face, difficulty breathing, and hives.